Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Alunacedase alfa
(Recombinant Human Angiotensin-Converting Enzyme 2) | [1] Recombinant Human Angiotensin-Converting Enzyme 2 Recombinant Human Angiotensin-Converting Enzyme 2 | - | - | - | [1] 86 86 💬
|
| 2 | Angiotensin II | [2] Angiotensin Angiotensin; Angiotensin II | [2] Angiotensin II
Angiotensin II
,Angiotensin II 💬 | [2] AGTR1 AGTR1,AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [7] 17 17, 19, 46, 66, 86, 222, 224 💬
|